1	7 If felbamate is used as a concomitant AED subjects must be on felbamate for at least 2 years with a stable dose for 60 days prior to Baseline They must not have a history of white blood cell WBC count below less than or euqal to 2500/microL 2.50 1E+09/L platelets less than 100,000/microL|felbamate[5,14]|||||||||C0060135|24812|24812|felbamate
1	7 If felbamate is used as a concomitant AED subjects must be on felbamate for at least 2 years with a stable dose for 60 days prior to Baseline They must not have a history of white blood cell WBC count below less than or euqal to 2500/microL 2.50 1E+09/L platelets less than 100,000/microL|felbamate[64,73]|||||||2 years[87,94]||C0060135|24812|24812|felbamate
2	liver function tests LFTs greater than 3 times the upper limit of normal ULN or other indication of hepatic or bone marrow dysfunction while receiving felbamate|felbamate[442,451]|||||||||C0060135|24812|24812|felbamate
